- Home
- ELWS vs ENSC Comparison
ELWS vs ENSC Comparison
Compare ELWS & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- ENSC
- Stock Information
- Founded
- ELWS 2018
- ENSC 2003
- Country
- ELWS Japan
- ENSC United States
- Employees
- ELWS N/A
- ENSC N/A
- Industry
- ELWS
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- ENSC Health Care
- Exchange
- ELWS Nasdaq
- ENSC Nasdaq
- Market Cap
- ELWS 6.2M
- ENSC 5.5M
- IPO Year
- ELWS 2023
- ENSC N/A
- Fundamental
- Price
- ELWS $2.18
- ENSC $2.50
- Analyst Decision
- ELWS
- ENSC
- Analyst Count
- ELWS 0
- ENSC 0
- Target Price
- ELWS N/A
- ENSC N/A
- AVG Volume (30 Days)
- ELWS 11.9K
- ENSC 23.5K
- Earning Date
- ELWS 03-03-2025
- ENSC 03-10-2025
- Dividend Yield
- ELWS N/A
- ENSC N/A
- EPS Growth
- ELWS N/A
- ENSC N/A
- EPS
- ELWS N/A
- ENSC N/A
- Revenue
- ELWS $2,292,406.00
- ENSC $5,210,031.00
- Revenue This Year
- ELWS N/A
- ENSC N/A
- Revenue Next Year
- ELWS N/A
- ENSC N/A
- P/E Ratio
- ELWS N/A
- ENSC N/A
- Revenue Growth
- ELWS 404.13
- ENSC 133.58
- 52 Week Low
- ELWS $1.04
- ENSC $2.12
- 52 Week High
- ELWS $8.68
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- ELWS 47.54
- ENSC 19.38
- Support Level
- ELWS $2.01
- ENSC $3.30
- Resistance Level
- ELWS $2.39
- ENSC $3.58
- Average True Range (ATR)
- ELWS 0.23
- ENSC 0.34
- MACD
- ELWS 0.06
- ENSC -0.06
- Stochastic Oscillator
- ELWS 55.71
- ENSC 1.91
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.